These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15650434)

  • 1. Interview with Marcelle C. Layton, MD assistant commissioner, Bureau of Communicable Disease New York City Department of Health and Mental Hygiene. Interview by Madeline Drexler.
    Layton MC
    Biosecur Bioterror; 2004; 2(4):245-50. PubMed ID: 15650434
    [No Abstract]   [Full Text] [Related]  

  • 2. Interview with David Byrne, WHO special envoy on the revision of the International Health Regulations, and former European Commissioner for Health and Consumer Protection. Interview by Madeline Drexler.
    Byrne D
    Biosecur Bioterror; 2005; 3(3):193-7. PubMed ID: 16181041
    [No Abstract]   [Full Text] [Related]  

  • 3. Interview with David S. Fedson, MD, Former Professor of Medicine, University of Virginia School of Medicine, and Director of Medical Affairs, Aventis Pasteur MSD by Madeline Drexler.
    Fedson DS
    Biosecur Bioterror; 2005; 3(1):9-15. PubMed ID: 15853450
    [No Abstract]   [Full Text] [Related]  

  • 4. Interview with David L. Heymann, MD, representative for polio eradication and former Executive Director, Communicable Diseases, World Health Organization. Interview by Madeline Drexler.
    Heymann DL
    Biosecur Bioterror; 2003; 1(4):233-7. PubMed ID: 15040202
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: the risk of anthrax and smallpox in Australia.
    Smallwood R
    Commun Dis Intell Q Rep; 2001 Nov; 25(4):188-9. PubMed ID: 11806654
    [No Abstract]   [Full Text] [Related]  

  • 6. Interview with Julie L. Gerberding, M.D., M.P.H. Director, Centers for Disease Control and Prevention. Interview by Madeline Drexler.
    Gerberding JL
    Biosecur Bioterror; 2003; 1(1):15-8. PubMed ID: 15040210
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparing for pandemic influenza: revisit the basics.
    Chan WF; Wong TK
    J Clin Nurs; 2007 Oct; 16(10):1858-64. PubMed ID: 17880474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interview with Donald F. Thompson, MD, MPH, TM Chief, Interagency and International Branch, North American Aerospace Defense Command -- United States Northern Command Surgeon's Office by Madeline Drexler.
    Thompson DF
    Biosecur Bioterror; 2004; 2(2):67-72. PubMed ID: 15225399
    [No Abstract]   [Full Text] [Related]  

  • 9. Interview with Joxel García, MD, deputy director, Pan American Health Organization. Interview by Madeline Drexler.
    García J
    Biosecur Bioterror; 2006; 4(1):14-9. PubMed ID: 16545021
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparedness for SARS, influenza, and bioterrorism.
    Ursano RJ
    Psychiatr Serv; 2005 Jan; 56(1):7. PubMed ID: 15637184
    [No Abstract]   [Full Text] [Related]  

  • 11. Syndromic surveillance for bioterrorism following the attacks on the World Trade Center--New York City, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Sep; 51 Spec No():13-5. PubMed ID: 12238536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefining of public health preparedness after 9/11.
    Farley TA; Weisfuse I
    Lancet; 2011 Sep; 378(9794):957-9. PubMed ID: 21890061
    [No Abstract]   [Full Text] [Related]  

  • 13. The pitfalls of bioterrorism preparedness: the anthrax and smallpox experiences.
    Cohen HW; Gould RM; Sidel VW
    Am J Public Health; 2004 Oct; 94(10):1667-71. PubMed ID: 15451727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robert P. Kadlec, MD, former Special Assistant to the President and Senior Director for Biodefense Policy, Homeland Security Council. Interview by Madeline Drexler.
    Kadlec RP
    Biosecur Bioterror; 2009 Mar; 7(1):17-23. PubMed ID: 19379101
    [No Abstract]   [Full Text] [Related]  

  • 15. Why collect individual-level vaccination data?
    Writing team for the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Vaccine Coverage Theme Group
    CMAJ; 2010 Feb; 182(3):273-5. PubMed ID: 20048007
    [No Abstract]   [Full Text] [Related]  

  • 16. Hospital emergency preparedness: Push-POD operation and pharmacists as immunizers.
    Veltri K; Yaghdjian V; Morgan-Joseph T; Prlesi L; Rudnick E
    J Am Pharm Assoc (2003); 2012; 52(1):81-5. PubMed ID: 22257620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Globalization and infectious diseases].
    Garavelli PL; Peduzzi P
    Recenti Prog Med; 2006 Oct; 97(10):528-32. PubMed ID: 17263043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early statistical detection of anthrax outbreaks by tracking over-the-counter medication sales.
    Goldenberg A; Shmueli G; Caruana RA; Fienberg SE
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5237-40. PubMed ID: 11959973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated case of bioterrorism-related inhalational anthrax, New York City, 2001.
    Holtz TH; Ackelsberg J; Kool JL; Rosselli R; Marfin A; Matte T; Beatrice ST; Heller MB; Hewett D; Moskin LC; Bunning ML; Layton M
    Emerg Infect Dis; 2003 Jun; 9(6):689-96. PubMed ID: 12781008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health's response to a changed world: September 11, biological terrorism, and the development of an environmental health tracking network.
    Marmagas SW; King LR; Chuk MG
    Am J Public Health; 2003 Aug; 93(8):1226-30. PubMed ID: 12893600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.